MYRIAD GENETICS INC

$MYGN
Smart money positioned

8 of the Top-200 alpha managers hold $MYGN as of the latest 13F snapshot.

13F holders
193
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

8 holders · Q1 2026

$MYGN is held by 8 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.21%, with an average of 0.04% of portfolio. Largest holder: Vestal Point Capital, LP at 0.21%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 193 · Source: 13F-HR
01
Sculptor Capital LP
2.45% of portfolio
125,000,000 sh
02
Evergreen Capital Management LLC
0.01% of portfolio
6,668,817 sh
03
State Street
5,966,567 sh
04
De Burlo Group Inc.
0.61% of portfolio
5,411,978 sh
05
Glenview Capital Management, LLC
0.74% of portfolio
4,587,407 sh
06
Commerce Bank
0.01% of portfolio
4,499,724 sh
07
Axa S.a.
4,424,027 sh
08
Marshall & Sullivan Inc.
0.04% of portfolio
4,176,984 sh
09
Nomura Asset Management Co. Ltd.
0.01% of portfolio
3,609,068 sh
10
Campbell Newman Asset Management Inc.
0.01% of portfolio
2,308,589 sh
See all 193 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $MYGN in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $MYGN in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:39 UTC.